Assessment of anti-factor Xa activity in critically ill COVID-19 patients receiving three different anticoagulation regimens

INTRODUCTION: Critically ill COVID-19 patients are at increased risk of thrombosis with an enhanced risk of bleeding. We aimed to explore the role of anti-factor Xa levels in optimizing the high-intensity anticoagulation’s safety and efficacy and finding possible associations between D-dimer levels,...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamad, Mohammed A, Dasuqi, Shereen A, Aleem, Aamer, Omran, Rasha A, AlQahtani, Rakan M, Alhammad, Fahad A, Alzeer, Abdulaziz H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516376/
https://www.ncbi.nlm.nih.gov/pubmed/34659762
http://dx.doi.org/10.1177/20503121211049931

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516376/
https://www.ncbi.nlm.nih.gov/pubmed/34659762
http://dx.doi.org/10.1177/20503121211049931

Ejemplares similares